Guoping Wang
Impact in
- Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis
- Multicomponent Synthesis of Heterocycles
- Catalytic C–H Functionalization Methods
- Click Chemistry and Applications
- Synthesis and biological activity
- Synthesis and Catalytic Reactions
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 3
-
- Ubiquitin and proteasome pathways 2
- Co-authors
- Zaneta Nikolovska‐Coleska (4 shared papers)Shaomeng Wang (4 shared papers)Ke Ding (3 shared papers)Sanjeev Shangary (3 shared papers)Dongguang Qin (2 shared papers)Yipin Lu (2 shared papers)Peter P. Roller (1 shared paper)Krzysztof Krajewski (1 shared paper)
- Journals
- BMC Ophthalmology (3 papers)Journal of Medicinal Chemistry (2 papers)Ophthalmology (2 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Guoping Wang
35 papers receiving 1.3k citations
Guoping Wang's Hit Papers
Peers
Comparison fields: 5 of 107
- Organic Chemistry 562
- Oncology 430
- Toxicology 35
- Molecular Biology 533
- Biotechnology 64
Countries citing papers authored by Guoping Wang
This map shows the geographic impact of Guoping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoping Wang more than expected).
Fields of papers citing papers by Guoping Wang
This network shows the impact of papers produced by Guoping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoping Wang. The network helps show where Guoping Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 Interaction Hit paper breakdown → | 2006 | 631 |
| 2 | 2009 | 156 | |
| 3 | 2007 | 131 | |
| 4 | 2008 | 78 | |
| 5 | 2003 | 66 | |
| 6 | 2016 | 40 | |
| 7 | 2008 | 37 | |
| 8 | 2016 | 34 | |
| 9 | 2012 | 18 | |
| 10 | 2022 | 17 | |
| 11 | 2021 | 13 | |
| 12 | 2016 | 13 | |
| 13 | 2024 | 12 | |
| 14 | 2013 | 11 | |
| 15 | 2013 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2021 | 7 | |
| 18 | 2016 | 7 | |
| 19 | 2013 | 6 | |
| 20 | 2024 | 6 |
About Guoping Wang
Guoping Wang is a scholar working on Oncology, Molecular Biology, Ophthalmology, Organic Chemistry and Surgery, having authored 38 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Ubiquitin and proteasome pathways (2 papers), MRI in cancer diagnosis (2 papers), Immunotherapy and Immune Responses (2 papers), Ocular Surface and Contact Lens (2 papers), Mesenchymal stem cell research (2 papers), Biological Stains and Phytochemicals (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Organic Chemistry (562 citations), Oncology (430 citations), Toxicology (35 citations), Molecular Biology (533 citations) and Biotechnology (64 citations). Guoping Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Zaneta Nikolovska‐Coleska, Shaomeng Wang, Ke Ding, Sanjeev Shangary, Dongguang Qin, Yipin Lu, Peter P. Roller, Krzysztof Krajewski, Jeanne A. Stuckey and Wei Gao. Their work appears in journals such as BMC Ophthalmology, Journal of Medicinal Chemistry, Ophthalmology, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.